From 2017 to 2022, the Active implanted medical devices market is expected to increase at a CAGR of 7.8%, reaching USD 26.75 billion. The primary growth drivers for the implantable and life-sustaining devices market are the ageing population, rising prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favourable reimbursement scenarios for ENT procedures in developed countries. However, adverse healthcare reforms in the United States, concerns over the use of implantable medical devices, and the high cost of implants may stymie the growth of this market.
The market is divided into two categories in this report: product and geography. Active implanted medical devices market cardioverter defibrillators, implanted cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices are the product segments of the market. Because of the rising incidence of cardiovascular diseases, the development of technologically advanced devices, and increased demand for these devices in emerging countries, the implantable cardioverter defibrillators segment accounted for the largest share of the implantable and life-sustaining devices market in 2016.
North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa are the regions that make up the worldwide market. North America accounted for a large portion of the global implantable and life-sustaining devices market in 2016. The growth in the geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region are all factors contributing to North America's largest share. During the projected period, however, Asia-Pacific is expected to increase at the fastest rate. The Asia-Pacific region is booming.
The growing geriatric population, rising incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructure development, growing demand for advanced technologies to develop advanced products, and less stringent regulations are all factors driving growth in the Asia-Pacific market.
In the future years, the active implanted medical devices market is predicted to increase significantly. The ageing population, rising prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favourable reimbursement scenarios for ENT procedures in developed countries are all factors driving the market's growth. The implantable and life-sustaining devices market is expected to grow at a CAGR of 7.8% from 2017 to 2022, reaching USD 26.75 billion from USD 18.42 billion in 2017.
However, adverse healthcare reforms in the United States, concerns over the use of implantable medical devices, and the high cost of implants may limit the market's growth. This market has substantial growth potential due to lucrative opportunities in emerging markets and the development of subcutaneous implanted cardioverter defibrillators. Active implanted medical devices market The primary trends in this industry include increasing market consolidation and the introduction of novel, easy-to-use implantable cardiovascular solutions with greater lifetime.
The market is examined by product and geography in this report. Implantable cardioverter defibrillators, implanted cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and active implanted medical devices market hearing devices are the product segments of the market. Because of the rising incidence of cardiovascular diseases, the development of technologically advanced devices, and increased demand for these devices in emerging countries, the implantable cardioverter defibrillators segment accounted for the largest share of the implantable and life-sustaining devices market in 2016.
North America led the active implanted medical devices market in 2016, with Europe, Asia-Pacific, Latin America, and the Middle East and Africa following closely behind. The primary factors driving the growth of this market are the rising prevalence of cardiovascular and neurological illnesses, high accessibility to modern technologies, increased creation of novel and technologically advanced goods, and rising healthcare expenditure in the region. The Asia-Pacific (APAC) area, on the other hand, is predicted to develop at the fastest rate during the forecast period.
Comments
Post a Comment